| Transmission of SARS-CoV-2: a review of viral, host, and environmental factors EA Meyerowitz, A Richterman, RT Gandhi, PE Sax Annals of internal medicine 174 (1), 69-79, 2021 | 1210 | 2021 |
| Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection ES Ford, JH Greenwald, AG Richterman, A Rupert, L Dutcher, ... Aids 24 (10), 1509-1517, 2010 | 244 | 2010 |
| Severe monkeypox in hospitalized patients—United States, August 10–october 10, 2022 MJ Miller MMWR. Morbidity and mortality weekly report 71, 2022 | 216 | 2022 |
| Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2 EA Meyerowitz, A Richterman, II Bogoch, N Low, M Cevik The Lancet infectious diseases 21 (6), e163-e169, 2021 | 214 | 2021 |
| Identification of racial inequities in access to specialized inpatient heart failure care at an academic medical center LA Eberly, A Richterman, AG Beckett, B Wispelwey, RH Marsh, ... Circulation: Heart Failure 12 (11), e006214, 2019 | 196 | 2019 |
| Hospital-acquired SARS-CoV-2 infection: lessons for public health A Richterman, EA Meyerowitz, M Cevik Jama 324 (21), 2155-2156, 2020 | 158 | 2020 |
| Effectiveness of contact tracing in the control of infectious diseases: a systematic review AD Hossain, J Jarolimova, A Elnaiem, CX Huang, A Richterman, LC Ivers The Lancet Public Health 7 (3), e259-e273, 2022 | 128 | 2022 |
| Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis D Buitrago-Garcia, AM Ipekci, L Heron, H Imeri, L Araujo-Chaveron, ... PLoS medicine 19 (5), e1003987, 2022 | 102 | 2022 |
| Cash interventions to improve clinical outcomes for pulmonary tuberculosis: systematic review and meta-analysis A Richterman, J Steer-Massaro, J Jarolimova, LBL Nguyen, ... Bulletin of the World Health Organization 96 (7), 471, 2018 | 99 | 2018 |
| The effects of cash transfers on adult and child mortality in low-and middle-income countries A Richterman, C Millien, EF Bair, G Jerome, JCD Suffrin, JR Behrman, ... Nature 618 (7965), 575-582, 2023 | 90 | 2023 |
| Individual and household risk factors for symptomatic cholera infection: a systematic review and meta-analysis A Richterman, DR Sainvilien, L Eberly, LC Ivers The Journal of infectious diseases 218 (suppl_3), S154-S164, 2018 | 88 | 2018 |
| New perspectives on antimicrobial agents: remdesivir treatment for COVID-19 MM Aleissa, EA Silverman, LM Paredes Acosta, CT Nutt, A Richterman, ... Antimicrobial agents and chemotherapy 65 (1), e01814-20, 2020 | 82 | 2020 |
| Indirect protection by reducing transmission: ending the pandemic with severe acute respiratory syndrome coronavirus 2 vaccination A Richterman, EA Meyerowitz, M Cevik Open Forum Infectious Diseases 9 (2), ofab259, 2022 | 68 | 2022 |
| Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome … PM Grant, L Komarow, MM Lederman, S Pahwa, AR Zolopa, J Andersen, ... The Journal of infectious diseases 206 (11), 1715-1723, 2012 | 65 | 2012 |
| An assessment of HIV-infected patients dying in care for deceased organ donation in a United States urban center A Richterman, D Sawinski, PP Reese, DH Lee, H Clauss, RD Hasz, ... American journal of transplantation 15 (8), 2105-2116, 2015 | 64 | 2015 |
| Clinical course and management of COVID-19 in the era of widespread population immunity EA Meyerowitz, J Scott, A Richterman, V Male, M Cevik Nature Reviews Microbiology 22 (2), 75-88, 2024 | 61 | 2024 |
| Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series JC Pearson, B Dionne, A Richterman, SJ Vidal, Z Weiss, GE Velásquez, ... Open forum infectious diseases 7 (10), ofaa415, 2020 | 52 | 2020 |
| The effects of cash transfer programmes on HIV-related outcomes in 42 countries from 1996 to 2019 A Richterman, H Thirumurthy Nature Human Behaviour 6 (10), 1362-1371, 2022 | 45 | 2022 |
| Covid-19 vaccination: evidence of waning immunity is overstated J Scott, A Richterman, M Cevik Bmj 374, 2021 | 42 | 2021 |
| SARS-CoV-2 transmission and prevention in the era of the Delta variant EA Meyerowitz, A Richterman Infectious disease clinics of North America 36 (2), 267, 2022 | 40 | 2022 |
Eric MeyerowitzMontefiore Medical CenterVerified email at montefiore.org
